Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Real-world remdesivir data add to body of evidence for Gilead Sciences Covid-19 drug
MedCity News
Tue, 06/22/21 - 11:09 am
Gilead Sciences
remdesivir
COVID-19
real world data
real world evidence
RWE
8 key clinical trials to watch for the rest of 2021
BioPharma Dive
Mon, 06/21/21 - 11:11 am
clinical trials
Merck
Ridgeback Biotherapeutics
COVID-19
Intellia Therapeutics
transthyretin amyloidosis
Arcus Biosciences
Gilead Sciences
lung cancer
Sanofi
GSK
vaccines
uniQure
Huntington's disease
Mirati Therapeutics
gene editing
Seres Therapeutics
ulcerative colitis
Sarepta Therapeutics
Duchenne Muscular Dystrophy
BMS will file for earlier-line use of Breyanzi in lymphoma after trial win
Pharmaforum
Fri, 06/11/21 - 10:49 am
Bristol Myers Squibb
CAR-T
Breyanzi
large B-cell lymphoma
Novartis
Gilead Sciences
FDA
Arcus nears crunch time for Gilead opt-in
EP Vantage
Thu, 06/10/21 - 10:47 am
Arcus Biosciences
anti-TIGIT
clinical trials
Gilead Sciences
monoclonal antibodies
ASCO21: Gilead sets up first FDA okay for adult ALL with Tecartus data
Pharmaforum
Mon, 06/7/21 - 11:07 am
ASCO 2021
Gilead Sciences
Tecartus
ALL
#ASCO21: A week after nabbing priority review, Kite unveils the pivotal data it hopes will lead to a new CAR-T approval
Endpoints
Sat, 06/5/21 - 02:25 pm
ASCO 2021
Kite Pharma
Gilead Sciences
CAR-T
Tecartus
#ASCO21: Gilead's Trodelvy reads out new subgroup data showing benefit in earlier-line TNBC patients
Endpoints
Fri, 06/4/21 - 11:00 am
Gilead Sciences
Trodelvy
breast cancer
triple negative breast cancer
ASCO 2021
#ASCO21: Novartis gears up for CAR-T fight with Gilead in follicular lymphoma — and safety could define the battle
Endpoints
Thu, 06/3/21 - 10:51 am
Novartis
ASCO 2021
CAR-T
Kymriah
follicular lymphoma
Gilead Sciences
Yescarta
Gilead's Q1 Results Show Just How Much the Biotech Is Relying on Its COVID Drug
Motley Fool
Fri, 04/30/21 - 10:34 am
Gilead Sciences
earnings
Gilead, Merck step in to help India's drug manufacturers fight surging COVID-19 outbreak
Fierce Pharma
Tue, 04/27/21 - 11:26 pm
Gilead Sciences
Merck
India
COVID-19
Quiet times return for biopharma takeouts
EP Vantage
Wed, 04/14/21 - 09:26 am
M&A
Alexion
Amgen
AstraZeneca
Biogen
Five Prime Therapeutics
Gilead Sciences
GW Pharma
Horizon Therapeutics
Immunomedics
Jazz Pharmaceutical
Kymab
Merck
Pandion
Sanofi
Viela Bio
Gilead stops Veklury study, citing enrollment challenges, changing treatment
BioPharma Dive
Tue, 04/13/21 - 10:05 pm
Gilead Sciences
COVID-19
remdesivir
Veklury
clinical trials
India axes exports of Gilead Sciences' remdesivir, plots boost to local production as COVID cases mount: reports
Fierce Pharma
Mon, 04/12/21 - 10:59 pm
India
drug manufacturing
Gilead Sciences
remdesivir
COVID-19
Gilead scores US approval for breast cancer drug that wowed ESMO
Pharmaforum
Thu, 04/8/21 - 10:23 am
Gilead Sciences
Trodelvy
FDA
ESMO
triple negative breast cancer
CEO Dan O'Day, tasked with boosting Gilead's oncology presence, scores $19M for a year focused on COVID
Fierce Pharma
Mon, 04/5/21 - 10:18 pm
Gilead Sciences
Daniel O'Day
executive pay
Pharma CEOs
Pharma Gilead has sole rights to COVID-19 blockbuster Veklury, GAO concludes
Fierce Pharma
Thu, 04/1/21 - 11:42 pm
Gilead Sciences
remdesivir
Veklury
GAO
COVID-19
Biotech pioneer and startup investor John Martin, who built Gilead into a powerhouse player, has died
Endpoints
Wed, 03/31/21 - 10:31 am
Gilead Sciences
John Martin
Pharma CEOs
How Gilead's and Merck's Surprise Partnership Will Shake Up the HIV Market
Motley Fool
Thu, 03/25/21 - 11:46 am
Gilead Sciences
Merck
HIV
drug development
Gilead, Novo Nordisk push NASH cocktail deeper into the clinic
Fierce Biotech
Thu, 03/18/21 - 10:54 am
Gilead Sciences
Novo Nordisk
NASH
R&D
Gilead, Merck combine forces in HIV
BioPharma Dive
Mon, 03/15/21 - 11:51 pm
Gilead Sciences
Merck
HIV
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »